The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
Clinical trial NCT05781633 · UNKNOWN
Trial details
- NCT number
- NCT05781633
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-20
- Primary completion
- 2023-07-20
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.